Ticker
ACXP

Price
2.54
Stock movement down
-0.08 (-3.05%)
Company name
Acurx Pharmaceuticals LLC
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
40.24M
Ent value
34.43M
Price/Sales
-
Price/Book
6.71
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
15.45%
3 year return
-25.41%
5 year return
-
10 year return
-
Last updated: 2024-07-18

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

ACXP does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book6.71
EV to Sales-

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count15.84M
EPS (TTM)-1.04
FCF per share (TTM)-0.71

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)0.00
Operating income (TTM)-3.46B
Net income (TTM)-16.05M
EPS (TTM)-1.04
EPS (1y forward)-1.59

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash8.92M
Net receivables0.00
Total current assets9.11M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets9.11M
Accounts payable3.11M
Short/Current long term debt0.00
Total current liabilities3.11M
Total liabilities3.11M
Shareholder's equity6.00M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-10.93M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-10.93M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-267.61%
Return on Assets-176.23%
Return on Invested Capital-267.61%
Cash Return on Invested Capital-182.22%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open2.87
Daily high3.33
Daily low2.50
Daily Volume857K
All-time high7.89
1y analyst estimate11.66
Beta-1.70
EPS (TTM)-1.04
Dividend per share-
Ex-div date-
Next earnings date12 Aug 2024

Downside potential

Loading...
Downside potential data
ACXPS&P500
Current price drop from All-time high-67.81%-2.16%
Highest price drop-83.78%-56.47%
Date of highest drop3 Oct 20239 Mar 2009
Avg drop from high-55.64%-11.26%
Avg time to new high771 days12 days
Max time to new high770 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ACXP (Acurx Pharmaceuticals LLC) company logo
Marketcap
40.24M
Marketcap category
Small-cap
Description
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Employees
4
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...